Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III

Tumori

Volumn 93, Issue 6, 2007, Pages 572-579

  Terra, Ana Paula Sarreta ^a   Murta, Eddie Fernando Candido ^a   Maluf, Paulo José ^a   Caballero, Otávia Luísa Silva Damas ^a   Brait, Mariana ^a   Adad, Sheila Jorge ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cervical intraepithelial neoplasia grade III; DAPk; E cad; GSTP1; Human papillomavirus; Methylation; MGMT; p14; p16; RAR ; Recurrence; TIMP3

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; COLPOSCOPY; FEMALE; GENOTYPE; HUMAN; HYSTERECTOMY; METHYLATION; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERUS BIOPSY; VERRUCA VULGARIS;

EID: 38549099046     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160709300610     Document Type: Article

References (42)

1. Zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW: Attempts to detect virus-specific DNA sequences in human tumors: I - Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer, 13: 650-656, 1974.
2. Zur Hausen H: Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta, 1288: 55-78, 1996.
3. Holowaty P, Miller AB, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst, 91: 252-258, 1999.
4. Munoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19: 1-5, 2000.
5. Schiffman MH, Brinton LA: The epidemiology of cervical carcinogenesis. Cancer, 76: 1888-1901, 1995.
6. Nakagawa H, Sugano K, Fuji T, Kubushiro K, Tsukazaki SF: Frequent detection of human papillomaviruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis. Anticancer Res, 22: 1655-1660, 2002.
7. Johnson TJ, Plieth AD, Crissman JD, Sarkar FH: HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Mod Pathol, 4: 461-465, 1991.
8. Sarkar FH, Crissman JD: Detection of human papillomavirus DNA sequences by polymerase chain reaction. Biotechniques, 9: 180-185, 1990.
9. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res, 49: 4682-4689, 1989.
10. Mouron SA, Abba MC, Guerci A, Gomez MA, Dulout FN, Golijow CD: Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papillomavirus types in preinvasive cervical lesions. Mutat Res, 21: 127-134, 2000.
11. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin, 50: 7-33, 2000.
12. Kim YI, Giuliano A, Hatch KD, Schneider A, Nour MA, Dallal GE, Selhub J, Mason JB: Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer, 74: 893-899, 1994.
13. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L: Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer, 75: 396-402, 1997.
14. Ferguson AT, Lapidus RG, Baylin SB, Davidson NE: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res, 55: 2279-2283, 1995.
15. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG: In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA, 96: 12754-12759, 1999.
16. Kang S, Kim J, Kim HB, Shim JW, Nam E, Kim SH, Ahn HJ, Choi YP, Ding B, Song K, Cho NH: Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol, 15: 74-82, 2006.
17. Virmani AK, Muller C, Rathi A, Zoechbauer-Muller S, Mathis M, Gazdar AF, Adi FG: Aberrant methylation during cervical carcinogenesis. Clin Cancer Res, 7: 584-589, 2001.
18. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB: Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst, 97: 273-282, 2005.
19. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, Termrungruanglert W, Tresukosol D, Niruthisard S, Mutirangura A: Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer, BMC Cancer, 6: 55, 2006.
20. Fong KM, Zimmerman PV, Smith PJ: Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer. Genes Chromosomes Cancer, 10: 183-189, 1994.
21. Matlashewski G: The cell biology of human papillomavirus transformed cells. Anticancer Res, 9: 1447-1456, 1989.
22. Barbosa M, Schlegel R: The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene, 4: 1529-1532, 1989.
23. de Roda Husman AM, Walboomers JM, van de Brule AJ, Meijer CJ, Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3′ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol, 76: 1057-1062, 1995.
24. Sanguinetti CJ, Dias Neto E, Simpson AJG: Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques, 17: 914-921, 1994.
25. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93: 9821-9826, 1996.
26. Remmink AJ, Walboomers JM, Heimerhorst, TJ, Voorhorst FJ, Rozendaal L, Risse EK, Meijer CJ, Kenemans P: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer, 61: 306-311, 1995.
27. Noronha V, Mello W, Villa L, Brito A, Macedo R, Bisi F, Mota R, Sassamoto K, Monteiro T, Linhares A: Papilomavírus humano associado a lesões de cérvix. Rev Soc Bras Med Trop, 32: 235-240, 1999.
28. Konno R, Paez C, Sato S, Yajima A, Fukao A: HPV histologic grade and age risk factors for the progression of cervical intraepithelial neoplasia. J Repr Med, 43: 561-566, 1998.
29. Cavalcanti SM, Frugulhetti IC, Passos MR, Fonseca ME, Oliveira LH: Prevalence of human papillomavirus DNA in female cervical lesions from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz, 89: 575-580, 1994.
30. Zehbe I, Rylander E, Edlund K, Wadell G, Wilander E: Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques. Virchows Arch: 428: 151-157, 1996.
31. Krul EJ, Van De Vijver MJ, Schuuring E, Van Kanten RW, Peters AA, Fleuren GJ: Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer, 9: 206-211, 1999.
32. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, Lorincz AT: Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol, 159: 293-296, 1988.
33. Lo KW, Wong YF, Chan MK, Li JC, Poon JS, Wang VW, Zhu SN, Zhang TM, He ZG, Wu QI, Li GD, Tam JS, Kahn T, Lam P, Cheung TH, Chung TK: Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 100: 327-331, 2002.
34. Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, Müller HM, Wiedemair A, Jerabek S, Müller-Holzner E, Goebel G, Marth C, Widschwendter M: Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res, 10: 3396-3400, 2004.
35. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 16: 168-174, 2000.
36. Lin Z, Gao M, Zhang X, Kim YS, Lee ES, Kim HK, Kim I: The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6 methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol, 131: 364-370, 2005.
37. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV: Frequent promotor methylation of CDH1, DAPK, RAR B, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer, 2: 24, 2003.
38. Cheung TH, Lo KW, Yim SF, Chan LK, Heung MS, Chan CS, Cheung AY, Chung TK, Wong YF: Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol, 93: 621-627, 2004.
39. Murta EFC, Resende AV, Souza MAH, Adad SJ, Salum R: Importance of surgical margins in conization for cervical intraepithelial neoplasia grade III. Arch Gynecol Obstet, 263: 42-44, 1999.
40. Maluf PJ, Adad SJ, Murta EFC: Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses. Tumori, 90: 473-477, 2004.
41. Murta EFC, Conti R, Rodovalho J, Barcelos ACM, Adad SJ, de Souza MAH: Outcome after treatment of high-grade squamous intraepithelial lesions: relation between colposcopically directed biopsy, conization and cervical loop excision. Eur J Gynaecol Oncol, 25: 587-590, 2004.
42. Murta EFC, Neves Júnior MA, Sempionato LR, Costa MC, Maluf PJ: Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases. Arch Gynec Obstet, 272: 261-264, 2005.